All In MedTech

FDA Clearance Tracker · P100006

AUGMENT BONE GRAFT

Premarket approval (PMA) is the pathway for the highest-risk devices. FDA reviews clinical evidence of safety and effectiveness before approving.

Last checked: Nov 19, 2026Latest source record: Sep 1, 2015 (this decision)Source: openFDAMethods & limitations

PMAFirst of its product code

Decided

Sep 1, 2015

Approved

Time to decision

2,035 days

Received Feb 4, 2010. Calendar days, including time FDA spent waiting on the applicant.

Pathway

PMA

Device class

Class III

The decision

FDA number
P100006
Device name
AUGMENT BONE GRAFT
Applicant location
Franklin, TN
Received
Feb 4, 2010
Decided
Sep 1, 2015
Decision
Approved
Supplements
12 in FDA's data for this PMA. See them on the FDA record

Device type

Device class
Class III

Every decision under product code NOX

FDA's approval statement

As written in FDA's record.

APPROVAL FOR AUGMENT® BONE GRAFT. THIS DEVICE IS INDICATED FOR USE AS AN ALTERNATIVE TO AUTOGRAFT IN ARTHRODESIS (I.E., SURGICAL FUSION PROCEDURES) OF THE ANKLE (TIBIOTALAR JOINT) AND/OR HINDFOOT (INCLUDING SUBTALAR, TALONAVICULAR, AND CALCANEOCUBOID JOINTS, ALONE OR IN COMBINATION), DUE TO OSTEOARTHRITIS, POST-TRAUMATIC ARTHRITIS, RHEUMATOID ARTHRITIS, PSORIATIC ARTHRITIS, AVASCULAR NECROSIS, JOINT INSTABILITY, JOINT DEFORMITY, CONGENITAL DEFECT, OR JOINT ARTHROPATHY IN PATIENTS WITH PREOPERATIVE OR INTRAOPERATIVE EVIDENCE INDICATING THE NEED FOR SUPPLEMENTAL GRAFT MATERIAL.

How new is this?

These are facts about FDA's records. They are not a judgment about the device.

  • This is the earliest decision in FDA's data under product code NOX (Filler, bone void, synthetic peptide).
  • It is not on FDA's public list of Breakthrough Devices with marketing authorization (list dated June 30, 2026). FDA does not publish which devices hold the designation before they are authorized, and the list is updated only a few times a year.

Source documents

Other decisions for Biomimetic Therapeutics, LLC

Matched on the applicant name as FDA recorded it. A company that files under several names will have more.

Company page

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.